Carfilzomib for Injection

Carfilzomib for Injection

Categories : Oncology

Product Packaging : 1 Vial

Product Composition : 60 mg

Carfilzomib for Injection is an advanced second-generation proteasome inhibitor used in the treatment of multiple myeloma, particularly in patients who have received prior therapies. It works by irreversibly inhibiting the 20S proteasome, leading to accumulation of damaged proteins in cancer cells and inducing apoptosis.

This targeted oncology injectable is typically supplied as a lyophilized powder for reconstitution, ensuring optimal stability, potency, and shelf life. Carfilzomib plays a crucial role in modern hematology-oncology protocols and is widely used in combination treatment regimens.

Manufactured under stringent sterile and oncology-grade conditions, Carfilzomib for Injection offered by Genliva Wellness LLP ensures high purity, safety, and consistent efficacy. As a trusted Carfilzomib Injection contract manufacturer and exporter from India, Genliva Wellness LLP provides oncology-focused third-party manufacturing, private label solutions, and global bulk supply.

Send Message

Carfilzomib for Injection is an advanced second-generation proteasome inhibitor used in the treatment of multiple myeloma, particularly in patients who have received prior therapies. It works by irreversibly inhibiting the 20S proteasome, leading to accumulation of damaged proteins in cancer cells and inducing apoptosis.

This targeted oncology injectable is typically supplied as a lyophilized powder for reconstitution, ensuring optimal stability, potency, and shelf life. Carfilzomib plays a crucial role in modern hematology-oncology protocols and is widely used in combination treatment regimens.

Manufactured under stringent sterile and oncology-grade conditions, Carfilzomib for Injection offered by Genliva Wellness LLP ensures high purity, safety, and consistent efficacy. As a trusted Carfilzomib Injection contract manufacturer and exporter from India, Genliva Wellness LLP provides oncology-focused third-party manufacturing, private label solutions, and global bulk supply.

Carfilzomib for Injection is commonly used in the treatment of:

  • Multiple myeloma (relapsed or refractory cases)
  • Patients previously treated with proteasome inhibitors or immunomodulatory agents
  • Used in combination chemotherapy regimens in hematology-oncology

This targeted anticancer injection is administered under strict medical supervision in oncology and hematology centers.

Lyophilized injectable dosage form provides significant benefits:


whatsapp-app